MYELOFIBROSIS (PMF)
Clinical trials for MYELOFIBROSIS (PMF) explained in plain language.
Never miss a new study
Get alerted when new MYELOFIBROSIS (PMF) trials appear
Sign up with your email to follow new studies for MYELOFIBROSIS (PMF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug reparixin aims to control myelofibrosis when standard treatment fails
Disease control Recruiting nowThis phase 2 study tests the drug reparixin in 10 people with myelofibrosis, a type of bone marrow cancer. Participants have advanced disease and cannot take or have not responded to standard JAK inhibitor therapy. They take reparixin pills three times daily for 6 months, with th…
Matched conditions: MYELOFIBROSIS (PMF)
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Massive new study aims to unlock secrets of rare blood cancers
Knowledge-focused Recruiting nowThis long-term observational study is enrolling 5,000 adults with myeloproliferative neoplasms (MPNs)—rare blood cancers like polycythemia vera and myelofibrosis. Researchers will collect health records, patient surveys, and insurance data over at least five years to track sympto…
Matched conditions: MYELOFIBROSIS (PMF)
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC